EFG Asset Management Americas Corp. Increases Stock Position in Exponent, Inc. (NASDAQ:EXPO)

EFG Asset Management Americas Corp. boosted its stake in Exponent, Inc. (NASDAQ:EXPOFree Report) by 38.7% in the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 47,409 shares of the business services provider’s stock after purchasing an additional 13,231 shares during the period. EFG Asset Management Americas Corp. owned approximately 0.09% of Exponent worth $4,510,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also recently modified their holdings of EXPO. Vanguard Group Inc. boosted its holdings in shares of Exponent by 5.8% in the first quarter. Vanguard Group Inc. now owns 5,286,652 shares of the business services provider’s stock worth $437,153,000 after buying an additional 291,047 shares during the last quarter. Conestoga Capital Advisors LLC increased its stake in shares of Exponent by 2.8% in the second quarter. Conestoga Capital Advisors LLC now owns 2,763,260 shares of the business services provider’s stock worth $262,841,000 after purchasing an additional 75,909 shares in the last quarter. Bank of New York Mellon Corp raised its position in shares of Exponent by 3.5% during the 2nd quarter. Bank of New York Mellon Corp now owns 534,520 shares of the business services provider’s stock valued at $50,844,000 after purchasing an additional 17,849 shares during the period. Norges Bank purchased a new position in shares of Exponent during the 4th quarter valued at $45,786,000. Finally, Raymond James & Associates boosted its holdings in Exponent by 4.1% in the 2nd quarter. Raymond James & Associates now owns 487,035 shares of the business services provider’s stock worth $46,327,000 after buying an additional 19,051 shares during the period. 92.37% of the stock is owned by institutional investors.

Exponent Price Performance

Shares of EXPO stock traded down $2.08 during mid-day trading on Friday, hitting $102.58. The company had a trading volume of 146,867 shares, compared to its average volume of 256,988. The company has a market capitalization of $5.20 billion, a P/E ratio of 51.81 and a beta of 0.66. The stock’s 50 day moving average price is $102.94 and its 200-day moving average price is $92.59. Exponent, Inc. has a 52-week low of $64.61 and a 52-week high of $108.80.

Exponent (NASDAQ:EXPOGet Free Report) last issued its quarterly earnings data on Thursday, July 25th. The business services provider reported $0.57 earnings per share for the quarter, beating analysts’ consensus estimates of $0.50 by $0.07. Exponent had a return on equity of 28.39% and a net margin of 19.35%. The firm had revenue of $132.43 million during the quarter, compared to analyst estimates of $130.83 million. During the same quarter last year, the business posted $0.50 earnings per share. The business’s quarterly revenue was up 2.1% compared to the same quarter last year. On average, equities research analysts expect that Exponent, Inc. will post 2.04 earnings per share for the current year.

Exponent Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Friday, September 20th. Shareholders of record on Friday, September 6th will be paid a $0.28 dividend. This represents a $1.12 dividend on an annualized basis and a yield of 1.09%. The ex-dividend date of this dividend is Friday, September 6th. Exponent’s payout ratio is 56.57%.

Wall Street Analyst Weigh In

Separately, Truist Financial reaffirmed a “buy” rating and issued a $120.00 price objective (up previously from $100.00) on shares of Exponent in a research note on Friday, July 26th.

Check Out Our Latest Stock Analysis on EXPO

Insider Transactions at Exponent

In related news, VP John Pye sold 3,956 shares of the business’s stock in a transaction on Tuesday, July 30th. The shares were sold at an average price of $105.00, for a total value of $415,380.00. Following the sale, the vice president now owns 28,422 shares in the company, valued at $2,984,310. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. In other Exponent news, Director Paul R. Johnston sold 7,000 shares of the company’s stock in a transaction that occurred on Monday, June 17th. The stock was sold at an average price of $95.50, for a total transaction of $668,500.00. Following the sale, the director now directly owns 80,742 shares in the company, valued at $7,710,861. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. Also, VP John Pye sold 3,956 shares of Exponent stock in a transaction that occurred on Tuesday, July 30th. The stock was sold at an average price of $105.00, for a total value of $415,380.00. Following the completion of the transaction, the vice president now owns 28,422 shares of the company’s stock, valued at approximately $2,984,310. The disclosure for this sale can be found here. Insiders have sold 17,956 shares of company stock valued at $1,754,690 in the last ninety days. Corporate insiders own 2.10% of the company’s stock.

About Exponent

(Free Report)

Exponent, Inc, together with its subsidiaries, operates as a science and engineering consulting company in the United States and internationally. The company operates in two segments, Engineering and Other Scientific, and Environmental and Health. The Engineering and Other Scientific segment provides services in the areas of biomechanics, biomedical engineering and sciences, buildings and structures, civil engineering, construction consulting, data sciences, electrical engineering and computer science, human factors, materials and corrosion engineering, mechanical engineering, polymer science and materials chemistry, thermal sciences, and vehicle engineering.

See Also

Institutional Ownership by Quarter for Exponent (NASDAQ:EXPO)

Receive News & Ratings for Exponent Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Exponent and related companies with MarketBeat.com's FREE daily email newsletter.